Baxter International (HAM:BTL) Quality Rank


HAM:BTL Baxter International Inc HAM:BTL
58 GF Score
Price €19.67
GF Value €29.91
! 7 Warning Signs
View Full Analysis

What is Baxter International Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Baxter International Quality Rank Related Terms

HAM:BTL
58GF Score
Baxter International Inc HAM:BTL
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Baxter International (HAM:BTL) Overvalued in 2026?

Based on GuruFocus' analysis, Baxter International stock appears to be undervalued. The current stock price of €19.67 is trading 34.3% below its estimated GF Value™ of €29.91.

Key valuation signals for HAM:BTL:

  • Quality Rank:
  • GF Value™: €29.91 vs. price of €19.67 (34.3% below fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the HAM:BTL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baxter International Business Description

Address One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
58GF Score

Get the complete analysis for HAM:BTL

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.67
Price
€29.91
GF Value